ENTERPRISE THERAPEUTICS HOLDINGS LIMITED

ENTERPRISE THERAPEUTICS HOLDINGS LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Persons with signficant control statements
  • Data Source
  • Overview

    Company NameENTERPRISE THERAPEUTICS HOLDINGS LIMITED
    Company StatusActive
    Legal FormPrivate limited company
    Company Number 12868901
    JurisdictionEngland/Wales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of ENTERPRISE THERAPEUTICS HOLDINGS LIMITED?

    • Other service activities n.e.c. (96090) / Other service activities

    Where is ENTERPRISE THERAPEUTICS HOLDINGS LIMITED located?

    Registered Office Address
    Sussex Innovation Centre Science Park Square
    BN1 9SB Falmer
    Brighton
    United Kingdom
    Undeliverable Registered Office AddressNo

    What are the latest accounts for ENTERPRISE THERAPEUTICS HOLDINGS LIMITED?

    OverdueNo
    Next Accounts
    Next Accounts Period End OnDec 31, 2026
    Next Accounts Due OnSep 30, 2027
    Last Accounts
    Last Accounts Made Up ToDec 31, 2025

    What is the status of the latest confirmation statement for ENTERPRISE THERAPEUTICS HOLDINGS LIMITED?

    Last Confirmation Statement Made Up ToSep 08, 2026
    Next Confirmation Statement DueSep 22, 2026
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToSep 08, 2025
    OverdueNo

    What are the latest filings for ENTERPRISE THERAPEUTICS HOLDINGS LIMITED?

    Filings
    DateDescriptionDocumentType

    Group of companies' accounts made up to Dec 31, 2025

    37 pagesAA

    Previous accounting period shortened from Jun 30, 2026 to Dec 31, 2025

    1 pagesAA01

    Statement of capital following an allotment of shares on Sep 23, 2025

    • Capital: GBP 231.173375
    7 pagesSH01

    Confirmation statement made on Sep 08, 2025 with updates

    7 pagesCS01

    Second filing for the appointment of Dr Peter Michael Finan as a director

    3 pagesRP04AP01

    Full accounts made up to Jun 30, 2025

    37 pagesAA

    Statement of capital following an allotment of shares on Aug 03, 2025

    • Capital: GBP 230.85739
    7 pagesSH01

    Previous accounting period shortened from Dec 31, 2025 to Jun 30, 2025

    1 pagesAA01

    Full accounts made up to Dec 31, 2024

    39 pagesAA

    Confirmation statement made on Sep 08, 2024 with updates

    7 pagesCS01

    Director's details changed for Dr John William Ford on Oct 05, 2020

    2 pagesCH01

    Statement of capital following an allotment of shares on Jul 01, 2024

    • Capital: GBP 230.77208
    7 pagesSH01

    Appointment of Dr Janet Margaret Justine Hammond as a director on May 20, 2024

    2 pagesAP01

    Group of companies' accounts made up to Dec 31, 2023

    35 pagesAA

    Resolutions

    Resolutions
    2 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of allotment of securities

    RES10
    capital

    Resolution of removal of pre-emption rights

    RES11
    incorporation

    Resolution of adoption of Articles of Association

    RES01

    Memorandum and Articles of Association

    72 pagesMA

    Appointment of Dr Robbie Woodman as a director on Jan 05, 2024

    2 pagesAP01

    Statement of capital following an allotment of shares on Jan 26, 2024

    • Capital: GBP 230.379075
    7 pagesSH01

    Statement of capital following an allotment of shares on Jan 26, 2024

    • Capital: GBP 193.57427
    6 pagesSH01

    Confirmation statement made on Sep 08, 2023 with no updates

    3 pagesCS01

    Group of companies' accounts made up to Dec 31, 2022

    41 pagesAA

    Confirmation statement made on Sep 08, 2022 with updates

    9 pagesCS01

    Memorandum and Articles of Association

    61 pagesMA

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of varying share rights or name

    RES12
    incorporation

    Resolution of adoption of Articles of Association

    RES01

    Particulars of variation of rights attached to shares

    5 pagesSH10

    Who are the officers of ENTERPRISE THERAPEUTICS HOLDINGS LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    BOYD, Philip James, Dr
    BN1 9SB Falmer
    Sussex Innovation Centre Science Park Square
    Brighton
    United Kingdom
    Secretary
    BN1 9SB Falmer
    Sussex Innovation Centre Science Park Square
    Brighton
    United Kingdom
    274015700001
    DZIKOWSKI, Bart
    Novartis Venture Fund, Novartis Campus
    Lichtstrasse 35
    Basel, 4056
    Forum 1-1.32
    Switzerland
    Director
    Novartis Venture Fund, Novartis Campus
    Lichtstrasse 35
    Basel, 4056
    Forum 1-1.32
    Switzerland
    SwitzerlandCanadian265813100001
    FINAN, Peter Michael, Dr
    George Street
    EH2 4JY Edinburgh
    137a
    Scotland
    Director
    George Street
    EH2 4JY Edinburgh
    137a
    Scotland
    EnglandBritish189408570001
    FORD, John William, Dr
    BN1 9SB Falmer
    Sussex Innovation Centre Science Park Square
    Brighton
    United Kingdom
    Director
    BN1 9SB Falmer
    Sussex Innovation Centre Science Park Square
    Brighton
    United Kingdom
    United KingdomBritish180692170003
    HAMMOND, Janet Margaret Justine, Dr
    BN1 9SB Falmer
    Sussex Innovation Centre Science Park Square
    Brighton
    United Kingdom
    Director
    BN1 9SB Falmer
    Sussex Innovation Centre Science Park Square
    Brighton
    United Kingdom
    United StatesAmerican324076240001
    MAYWEG, Alexander Volker, Dr
    Aeschenvorstadt
    4051
    Basel
    36
    Switzerland
    Director
    Aeschenvorstadt
    4051
    Basel
    36
    Switzerland
    SwitzerlandGerman275125800001
    MULDER, Geert-Jan, Dr
    Naarden
    1411dc
    Gooimeer 2-35
    Netherlands
    Director
    Naarden
    1411dc
    Gooimeer 2-35
    Netherlands
    NetherlandsDutch275125830001
    MUNSHI, Amit
    BN1 9SB Falmer
    Sussex Innovation Centre Science Park Square
    Brighton
    United Kingdom
    Director
    BN1 9SB Falmer
    Sussex Innovation Centre Science Park Square
    Brighton
    United Kingdom
    United StatesAmerican,Swiss275125880001
    RICHARDSON, Johnathan Craig, Dr
    3 Pancras Square
    Kings Cross
    N1C 4AG London
    2nd Floor
    United Kingdom
    Director
    3 Pancras Square
    Kings Cross
    N1C 4AG London
    2nd Floor
    United Kingdom
    United KingdomBritish262695000001
    WOODMAN, Robbie, Dr
    31 Milano
    20124 Milan
    Via Boscovich
    Italy
    Director
    31 Milano
    20124 Milan
    Via Boscovich
    Italy
    United KingdomBritish318943960001
    BOYD, Philip James, Dr
    BN1 9SB Falmer
    Sussex Innovation Centre Science Park Square
    Brighton
    United Kingdom
    Director
    BN1 9SB Falmer
    Sussex Innovation Centre Science Park Square
    Brighton
    United Kingdom
    United KingdomBritish274015690001

    Who are the persons with significant control of ENTERPRISE THERAPEUTICS HOLDINGS LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Dr Philip James Boyd
    BN1 9SB Falmer
    Sussex Innovation Centre Science Park Square
    Brighton
    United Kingdom
    Sep 09, 2020
    BN1 9SB Falmer
    Sussex Innovation Centre Science Park Square
    Brighton
    United Kingdom
    Yes
    Nationality: British
    Country of Residence: United Kingdom
    Natures of Control
    • The person holds, directly or indirectly, more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.

    What are the latest statements on persons with significant control for ENTERPRISE THERAPEUTICS HOLDINGS LIMITED?

    Persons with signficant control statements
    Notified OnCeased OnStatement
    Oct 07, 2020The company knows or has reasonable cause to believe that there is no registrable person or registrable relevant legal entity in relation to the company

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0